Carlsmed CARL
NASDAQ CARL
$14.76 +0.58 (+4.09%)
As of: Oct 21, 2026 · 2:42 PM EDT

Carlsmed (CARL) EBITDA (2024 - 2026)

Updated

Carlsmed's EBITDA came in at -$10.91 million for Q2 2026, compared with -$6.44 million a year earlier.

Analysis

Carlsmed (CARL) EBITDA (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Carlsmed reported EBITDA of -$38.26 million; for FY2025, it came in at -$30.29 million.

  • Going back by year, EBITDA was -$23.98 million in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q3 2024.
  • Business Quant data shows CARL's EBITDA at -$9.18 million (Q1 2026), -$9.22 million (Q4 2025) and -$8.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 257.75 Bn 236.78 Bn 4.88 Bn 2.90 Bn
2 Abbott Laboratories 172.35 Bn 142.78 Bn 7.27 Bn 2.75 Bn
3 Danaher 163.38 Bn 147.19 Bn 3.61 Bn 1.79 Bn
4 Intuitive Surgical 152.31 Bn 131.74 Bn 1.96 Bn 1.19 Bn
5 Medtronic 119.66 Bn 84.91 Bn 6.34 Bn 2.49 Bn
6 Stryker 114.04 Bn 100.16 Bn 4.50 Bn 1.96 Bn
7 Boston Scientific 65.43 Bn 60.20 Bn 3.85 Bn 1.53 Bn
8 Becton Dickinson 53.59 Bn 50.74 Bn 2.32 Bn 1.23 Bn
9 Edwards Lifesciences 50.98 Bn 34.98 Bn 1.35 Bn 555.90 Mn
10 Carlsmed 401.47 Mn -58.12 Mn 14.54 Mn -10.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.91 Mn
Mar 31, 2026 -9.18 Mn
Dec 31, 2025 -9.22 Mn
Sep 30, 2025 -8.95 Mn
Jun 30, 2025 -6.44 Mn
Mar 31, 2025 -5.68 Mn
Dec 31, 2024 -4.66 Mn
Sep 30, 2024 -7.74 Mn
API Access

Carlsmed EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CARL&period=max&api_key=YOUR_API_KEY